Nanoparticle technology offers significant market opportunities in pharmaceuticals and biomedicine, enhancing drug delivery, solubility, and targeted therapy. This field supports advancements in ...
Texas Biomed expanding work — and revenue base — with Big Pharma; seen as key to its competitiveness
Before the COVID-19 pandemic, Texas Biomedical Research Institute had established itself as a go-to researcher of infectious diseases, along with therapeutics and vaccines to combat them. It was ...
Johnson & Johnson has teamed up with BioMed X Institute to advance oral delivery of monoclonal antibodies and other biologics. The initiative will support the work of a small team that will work to ...
CEO David Hochman and co-founder Darren Sherman ran an accelerator model together in 2009, Accelerator Technologies, Inc. working with unmet needs to create intellectual property around high-impact ...
NEW YORK, July 8, 2020 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today it has entered into an exclusive Named Patient Program distribution agreement ...
CAMBRIDGE, Mass., July 1, 2020 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc. was formed today through the merger of Tolero Pharmaceuticals, Inc., and Boston Biomedical, Inc., two ...
DALLAS, TX and WARWICK, RI - Feb 12, 2013) - TissueGen® Inc., developer of a cutting-edge absorbable polymer technology for implantable drug delivery across a wide variety of therapeutic applications, ...
CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (LFCR) (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and ...
Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) to be used in EU countries' ...
Even bio execs get the blues. Even bio execs get the blues. Yes, it's been a troubling winter for those in the drug discovery business. Vioxx, the Merck drug for arthritis pain, has been withdrawn ...
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...
It appears we are entering the winter of our discontent regarding the discovery and delivery of effective pharmaceutical drugs. One example of citizen discomfort is the growing populist movement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback